Oculis Holding Ag - (OCS) closed at $7.64 on November 13, 2026, up 1.9% from the previous close, on volume of 171,848 shares (30-day average 317,736).
Data as of November 13, 2026.
Globe Newswire (Mon, 16-Nov 2:00 AM ET)
Globe Newswire (Mon, 9-Nov 2:00 AM ET)
Market Chameleon (Wed, 4-Nov 3:34 AM ET)
Globe Newswire (Tue, 3-Nov 4:05 PM ET)
Globe Newswire (Mon, 2-Nov 2:00 AM ET)
Market Chameleon (Fri, 30-Oct 7:07 AM ET)
Globe Newswire (Thu, 29-Oct 5:38 AM ET)
Globe Newswire (Thu, 22-Oct 2:00 AM ET)
Globe Newswire (Tue, 20-Oct 2:00 AM ET)
Globe Newswire (Mon, 19-Oct 2:00 AM ET)
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Oculis Holding Ag - trades on the NASDAQ stock market under the symbol OCS.
As of November 16, 2026, OCS stock price declined to $7.60 with 107,161 million shares trading.
OCS has a beta of 2.72, meaning it tends to be more sensitive to market movements. OCS has a correlation of 0.14 to the broad based SPY ETF.
OCS has a market cap of $439.33 million. This is considered a Small Cap stock.
Last quarter Oculis Holding Ag - reported $8,619 in Revenue and -$.37 earnings per share. This fell short of revenue expectation by $-281,381 and exceeded earnings estimates by $.12.
In the last 3 years, OCS traded as high as $34.48 and as low as $6.78.
The top ETF exchange traded funds that OCS belongs to (by Net Assets): SBIO, GWX, ONEQ, BBC.
OCS has underperformed the market in the last year with a price return of -60.6% while the SPY ETF gained +11.5%. OCS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.7% and -8.0%, respectively, while the SPY returned -4.4% and -1.9%, respectively.
OCS support price is $7.27 and resistance is $8.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OCS shares will trade within this expected range on the day.